Mettler-Toledo International Inc. (NYSE:MTD) Shares Purchased by Alliancebernstein L.P.

Alliancebernstein L.P. grew its holdings in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 9.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 583,181 shares of the medical instruments supplier’s stock after purchasing an additional 52,726 shares during the period. Alliancebernstein L.P. owned 2.76% of Mettler-Toledo International worth $713,627,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. JPMorgan Chase & Co. lifted its holdings in Mettler-Toledo International by 14.7% in the third quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock worth $332,634,000 after acquiring an additional 28,478 shares during the last quarter. M&T Bank Corp lifted its holdings in shares of Mettler-Toledo International by 14.3% in the 3rd quarter. M&T Bank Corp now owns 4,926 shares of the medical instruments supplier’s stock worth $7,387,000 after purchasing an additional 615 shares during the last quarter. Allworth Financial LP lifted its holdings in shares of Mettler-Toledo International by 367.4% in the 4th quarter. Allworth Financial LP now owns 215 shares of the medical instruments supplier’s stock worth $285,000 after purchasing an additional 169 shares during the last quarter. Nordea Investment Management AB grew its stake in Mettler-Toledo International by 29.8% during the 4th quarter. Nordea Investment Management AB now owns 105,823 shares of the medical instruments supplier’s stock worth $129,919,000 after buying an additional 24,285 shares during the last quarter. Finally, Robeco Institutional Asset Management B.V. increased its position in Mettler-Toledo International by 18.0% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 34,370 shares of the medical instruments supplier’s stock worth $42,058,000 after buying an additional 5,234 shares during the period. 95.07% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

MTD has been the subject of several analyst reports. Wolfe Research assumed coverage on shares of Mettler-Toledo International in a report on Friday, December 13th. They set a “peer perform” rating for the company. Wells Fargo & Company upped their target price on shares of Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the stock an “equal weight” rating in a research report on Monday, February 10th. Evercore ISI lifted their price target on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an “outperform” rating in a report on Monday, February 10th. Robert W. Baird increased their price objective on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the stock a “neutral” rating in a report on Monday, February 10th. Finally, Citigroup cut their target price on Mettler-Toledo International from $1,450.00 to $1,400.00 and set a “neutral” rating on the stock in a research note on Tuesday, March 4th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $1,380.50.

Mettler-Toledo International Stock Performance

MTD opened at $1,176.04 on Monday. The company has a market capitalization of $24.51 billion, a PE ratio of 29.02, a P/E/G ratio of 3.30 and a beta of 1.15. The stock’s fifty day moving average is $1,283.84 and its 200-day moving average is $1,302.91. Mettler-Toledo International Inc. has a one year low of $1,142.91 and a one year high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 EPS for the quarter, topping the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. On average, equities research analysts forecast that Mettler-Toledo International Inc. will post 42.71 EPS for the current fiscal year.

Insider Buying and Selling

In other news, insider Gerry Keller sold 600 shares of the firm’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total transaction of $810,804.00. Following the completion of the sale, the insider now directly owns 6 shares of the company’s stock, valued at $8,108.04. This trade represents a 99.01 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Christian Magloth sold 790 shares of Mettler-Toledo International stock in a transaction on Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the completion of the transaction, the insider now owns 734 shares in the company, valued at $964,248.46. The trade was a 51.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.94% of the stock is currently owned by insiders.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.